Pilot Grants are a program run by Movember’s men’s health partner, Prostate Cancer Canada, which awards grants that could significantly advance the field of prostate cancer study. With these grants many novel ideas for the prevention, diagnosis and treatment have been funded and Dr. Bouchard’s findings are the result of one.
Data from analyzes showed that evidence that GATA3 is lost during the progression from benign to cancerous cells. This research confirmed the hypothesis that the loss of GATA3, or when it is turned off, is an important event that contributes to cancer progression. This is not only important for developing methods for prevention, but is also a promising marker for the identification of new tumours.
Each year funds raised during Movember help support the pilot grant program. In 2010 there were 18 grants awarded. More information on last year’s grant recipients is available here.
For more information about programs funded by Movember check here.
![](http://cdn.movember.com/uploads/images/News/CA/2011/CA%20gene_news_article.jpg)